Skip to content

Clinical trials

Phase 2 Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 2 Clear all

208 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20034
20042
200510
20066
20078
200811
200910
201010
201113
201213
20133
20147
201512
20166
20178
20188
20194
20209
20219
20226
202310
20246
202512
202616

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed95
Terminated31
Recruiting27
Unknown status18
Active, not recruiting15
Not yet recruiting12
Withdrawn10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins8
M.D. Anderson Cancer Center6
UNICANCER6
Novartis Pharmaceuticals5
Fudan University4
National Cancer Institute (NCI)4
University Health Network, Toronto4
Eli Lilly and Company3
Endocyte3
Memorial Sloan Kettering Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma208
Neoplasms35
Pancreatic Neoplasms29
Stomach Neoplasms29
Carcinoma, Non-Small-Cell Lung28
Neoplasm Metastasis26
Carcinoma24
Prostatic Neoplasms20
Carcinoma, Squamous Cell16
Esophageal Neoplasms14

Trials

Showing 1 to 25 of 208. Each trial links to its page on Pharma Observatory.

108 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.